SCHEMBL23529282

SCHEMBL23529282

O=c1cc(CN2CCNCC2)cn[nH]1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.46
▸ SYK P43405 7/20 0.44
▸ CXCR4 P61073 6/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ CCR2 P41597 1/20 0.42
▸ CXCL12 P48061 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ JAK2 O60674 5/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CRBN Q96SW2 1/20 0.41
▸ TRPC5 Q9UL62 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26098964 0.73 SIGMAR1 (0.52) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL5757671 0.71 CHRNB2 (0.53) SIGMAR1CHRM2CHRM1
Hydrochloric Acid SCHEMBL4812347 0.70 CHRNB2 (0.51) SIGMAR1CHRM2CHRM1
SCHEMBL29297495 0.70 PARP1 (0.45) SIGMAR1
SCHEMBL4757486 0.69 SIGMAR1 (0.47) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL22422495 0.69 CHRNB2 (0.54) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL27969917 0.69 CHRNB2 (0.47) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL13770498 0.69 CXCR4 (0.49) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL29566635 0.69 CHRNB2 (0.54) SIGMAR1CXCR4MEN1CHRM2CHRM1
SCHEMBL26665904 0.68 SIGMAR1 (0.55) SIGMAR1CXCR4MEN1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127273-A1 1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS GB004, INC. (US) 2021-06-24 — — WO disclosed
WO-2021127273-A1 1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS GB004, INC. (US) 2021-06-24 — — WO disclosed
Send feedback